Biheteroaryl compounds and uses thereof

USRE47848E1 · kind E1 · reissue

Assignee

• Genentech, Inc. · US

Inventors

• Anthony Estrada · Redwood City, US
• Alan G. Olivero · South San Francisco, US
• Snahel Patel · South San Francisco, US
• Michael Siu · Burlingame, US
• Joseph P. Lyssikatos · South San Francisco, US
• Malcolm Huestis · South San Francisco, US
• Terry Kellar · Monroeville, US

Key dates

• Filing date: Feb 22, 2018
• Grant date: Feb 11, 2020
• Expiry date: Feb 22, 2038

Classification

• Technology area (CPC —): General

Abstract

The present invention provides for compounds of Formula I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R1, R2, R3, X1, X2, A and Cy variable in Formula all have the meaning as defined herein.